XML 16 R4.htm IDEA: XBRL DOCUMENT v3.26.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 2,962,709 $ 3,110,752 $ 9,380,076 $ 9,005,811
General and administrative 3,939,612 2,618,679 8,585,541 12,524,503
Total operating expenses 6,902,321 5,729,431 17,965,617 21,530,314
Loss from operations (6,902,321) (5,729,431) (17,965,617) (21,530,314)
Interest expense, net (99,950) (62,340) (269,503) (124,944)
Change in fair value of warrants (1,530) 64,959 23,124 57,406
Net loss (7,003,801) (5,726,812) (18,211,996) (21,597,852)
Net loss attributable to common stockholders, basic (7,197,006) (5,862,428) (18,757,284) (22,007,715)
Net loss attributable to common stockholders, diluted $ (7,197,006) $ (5,862,428) $ (18,757,284) $ (22,007,715)
Net loss per share attributable to common stockholders, basic $ (1.76) $ (1.50) $ (4.93) $ (5.88)
Net loss per share attributable to common stockholders, diluted $ (1.76) $ (1.50) $ (4.93) $ (5.88)
Weighted-average common stock outstanding, basic 4,097,711 3,920,576 3,805,866 3,741,732
Weighted-average common stock outstanding, diluted 4,097,711 3,920,576 3,805,866 3,741,732